← SynDRA
CGS-20625
SynDRA canonical compound SYN0087292 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | GABRA6 |
|---|
| Mechanism of action | Benzodiazepine receptor agonist |
|---|
All known targets
- GABRA1
- GABRA2
- GABRA3
- GABRA4
- GABRA5
- GABRA6
Mechanisms of action (all sources)
- Benzodiazepine receptor agonist
- GABA benzodiazepine site receptor partial agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- HDAC6
- HPGD
- HSD17B10
- KDM4E
- SMN1
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Look up CGS-20625 in the interactive SynDRA portal →